Rapport Therapeutics, Inc. Common Stock

$37.80
-2.09 (-5.24%)

Volume:

305.569K ($11.63M)

Market Capitalization:

$1.81B

Rapport Therapeutics Price Chart

Rapport Therapeutics Price Chart11:59 AM1:19 PM2:39 PM3:59 PM5:19 PM6:39 PM7:59 PM39.4839.1338.7738.4138.0537.6937.34

Rapport Therapeutics Volume Chart

Rapport Therapeutics Volume Chart11:59 AM1:19 PM2:39 PM3:59 PM5:19 PM6:39 PM7:59 PM17.48K14.98K12.48K9.99K7.49K4.99K2.50K

Rapport Therapeutics Market Segments

After Hours

-0.24(-0.63%)
Open$38.04
Close$37.80
Low$37.80
Low Change-0.24 (-0.63%)
High$38.04
High Change+0.00 (+0.00%)
Range$0.24
Volume302
Dollar Volume$11.42K

Regular Trading Hours

-1.93(-4.82%)
Open$39.97
Close$38.05
Low$37.11
Low Change-2.86 (-7.16%)
High$40.80
High Change+0.83 (+2.08%)
Range$3.69
Volume305.267K
Dollar Volume$11.61M

Premarket

*No Trades in Segment

After Hours Yesterday

+0.00(+0.00%)
Open$39.93
Close$39.93
Low$39.93
Low Change0.00 (0.00%)
High$39.93
High Change+0.00 (+0.00%)
Range$0.00
Volume111
Dollar Volume$4.43K

Regular Trading Hours Yesterday

+2.37(+6.32%)
Open$37.52
Close$39.89
Low$36.36
Low Change-1.16 (-3.09%)
High$40.60
High Change+3.08 (+8.21%)
Range$4.24
Volume915.095K
Dollar Volume$36.50M

Premarket Yesterday

*No Trades in Segment

Rapport Therapeutics Moving Averages

5 Day Moving Average (SMA5)$36.40
10 Day Moving Average (SMA10)$35.38
20 Day Moving Average (SMA20)$36.12
50 Day Moving Average (SMA50)$32.21
100 Day Moving Average (SMA100)$30.32
200 Day Moving Average (SMA200)$26.57

Rapport Therapeutics Statistics

Average Volume (30 Days)325.79K
P/E Ratio (Current)-15.91
EPS (Current)-$2.33
Dividend Yield0.00%
Free Cash Flow-$88.09M
Cash Ratio2.76
Current Ratio26.17
Quick Ratio26.17
Debt to Equity0.00
Enterprise Value$1.72B
EV to EBITDA-13.85
EV to Sales
Price to Book3.66
Price to Cash Flow
Price to Free Cash Flow
Price to Sales
Return on Assets-0.22%
Return on Equity-0.23%

Rapport Therapeutics Stock Splits

There have been no stock splits for Rapport Therapeutics (RAPP).

Rapport Therapeutics Dividends

There have been no dividends for Rapport Therapeutics (RAPP).